Clinical Trial Update: Pancreatic Adenocarcinoma Signature Stratification for Treatment [Phase 2]

View source ↗

Summary

Phase 2 pancreatic cancer trial focusing on signature-based stratification for treatment. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: COMPLETED